Navigation Links
Jesper Bramming, former A.P. Moller Executive, Joins the CMC Biologics Executive Management Team as Chief Financial Officer
Date:1/7/2014

COPENHAGEN, Denmark and SEATTLE, Jan. 7, 2014 /PRNewswire/ -- CMC Biologics, a leading biopharmaceutical process development and biopharmaceutical manufacturing organization, announced today that it has appointed Jesper Bramming as Chief Financial Officer (CFO) of its global operations.

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

Jesper Bramming brings more than 25 years of financial and management experience to CMC Biologics' Executive Management Team, including 9 years as CFO at financial service provider Nets Holding and in two subsidiaries in A. P. Moller – Maersk Group: Maersk Oil & Gas and Svitzer.

Mr. Bramming has previously held international management positions as an equity portfolio manager and financial analyst at A. P. Moller Maersk and within the banking industry. He holds a Master of Economics from the University of Copenhagen and has completed executive education programs at Columbia University, including the Columbia Senior Executive Program.

"We're very pleased to welcome Jesper to our global executive team managing financial operations in both Copenhagen and North American. The breadth of his international finance and financial services expertise is impressive, and we expect him to play a key role in preparing CMC Biologics for its next phase of success," said Claes Glassell, Chief Executive Officer of CMC Biologics.

"CMC Biologics has outstanding process development and manufacturing expertise to serve sophisticated clinical and commercial biopharmaceutical markets," said Jesper Bramming. "I am excited to join the company as it embarks on a new level of growth and I look forward to contributing to the team's execution of its development plan."

About CMC Biologics
CMC Biologics is committed to delivering world class biopharmaceutical process development and manufacturing services, specializing in custom services for scale up and cGMP manufacture of protein-based therapeutics for preclinical, clinical trials, and commercial production. The Company's fully integrated services includes cell line development using its proprietary CHEF1® system, process and formulation development, and comprehensive analytical testing. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers stirred tank and perfusion production processes. To learn more, visit www.cmcbiologics.com.

Media Contacts:
Stacie D. Byars
CMC Biologics Global Marketing
sbyars@cmcbio.com
+1 (206) 660-2588


'/>"/>
SOURCE CMC Biologics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cargill’s Dielectric Transformer Oil Made from Natural Esters Wins Presidential Green Chemistry Award
2. Everest Group Recognizes TCS as a Global Leader and Star Performer in Life Sciences IT Outsourcing
3. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
4. McCord Research Hires Former University of Iowa Researcher
5. Former Life Technologies and BD Biosciences Executive John L. "Kip" Miller Joins Solulinks Board of Directors
6. Former Head of UK Medicines & Healthcare Products Regulatory Agency (MHRA) Sir Alasdair Breckenridge Joins NDA Partners
7. Former COO and CSO of IDEXX Laboratories, Inc. Joins Board of Directors for Vet-Stem, Inc.
8. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
9. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
10. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
11. Utah, There is No Better Place U.S. Chamber of Commerce Ranks Utah as the Top Performer in the Nation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- On Thursday, March 23, 2017, the ... 0.07%; the Dow Jones Industrial Average edged 0.02% lower, ... at 2,345.96, marginally dropping 0.11%. US markets saw a ... sectors finished in red, and 1 sector ended flat ... coverage on the following Biotechnology equities: BioDelivery Sciences International ...
(Date:3/23/2017)... Research and Markets has announced the addition of ... offering. ... The Global Market for Bioproducts Should Reach $714.6 Billion ... of 8.9%, This research report quantifies the ... product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite ...
(Date:3/23/2017)... ... 23, 2017 , ... Ellen Matloff, president and CEO of ... as a 2017 Women of Innovation® finalist. Matloff will be among several women ... The dinner recognizes women accomplished in science, technology, engineering and math (STEM), along ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
Breaking Biology Technology:
(Date:3/22/2017)... 21, 2017 Vigilant Solutions , a ... enforcement agencies, announced today the appointment of retired FBI ... public safety business development. Mr. Sheridan brings ... including a focus on the aviation transportation sector, to ... position, Mr. Sheridan served as the Aviation Liaison Agent ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
Breaking Biology News(10 mins):